-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Apomorphine in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Apomorphine in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Apomorphine in Parkinson's Disease Drug Details: Staccato apomorphine is under development for...
-
Product Insights
Inhalers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Inhalers Pipeline Market Report Overview Inhalers deliver medication to the lungs. The inhalers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segment ·       Dry Powder Inhaler Devices Key Territories ·       The US ·       Europe ·       Australia...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AZ-002 in Seizures
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AZ-002 in Seizures report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AZ-002 in Seizures Drug Details: Alprazolam (AZ-002) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Apomorphine in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Apomorphine in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Apomorphine in Parkinson's Disease Drug Details:Staccato apomorphine is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Granisetron in Emesis (Vomiting)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Granisetron in Emesis (Vomiting) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Granisetron in Emesis (Vomiting) Drug Details:Staccato Granisetron is under development for the acute...
-
Product Insights
Inhalable Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Inhalable Drug Delivery Pipeline Market Report Overview An inhalable drug delivery device is meant to administer medications that are to be inhaled deeply into the lungs. Drugs are delivered either by the nasal or oral respiratory route. The Inhalable Drug Delivery pipeline market research report provides comprehensive information about the inhalable drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       ...
-
Company Profile
Alexza Pharmaceuticals Inc – Company Profile
Alexza Pharmaceuticals Inc (Alexza), a subsidiary of Ferrer Therapeutics Inc, focuses on the research, development, and commercialization of novel, proprietary products for the treatment of acute central nervous system diseases. The company develops its products based on its own proprietary technology, the Staccato system (a hand-held inhaler), which is the foundation for Adasuve (loxapine) and all other product candidates. The company’s lead product Adasuve (Staccato loxapine) is indicated for the treatment of agitation associated with schizophrenia or bipolar I disorder....
Add to Basket -
Product Insights
Net Present Value Model: Alprazolam
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Alprazolam Drug Details Alprazolam (AZ-002) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – apomorphine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry apomorphine Drug Details Staccato apomorphine is under development for the treatment of Parkinson's disease....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – granisetron
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry granisetron Drug Details Staccato Granisetron is under development for the acute treatment of cyclic...